• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性丘脑底核刺激可降低帕金森病患者的药物需求。

Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.

作者信息

Moro E, Scerrati M, Romito L M, Roselli R, Tonali P, Albanese A

机构信息

Istituto di Neurologia Università Cattolica del Sacro Cuore, Rome, Italy.

出版信息

Neurology. 1999 Jul 13;53(1):85-90. doi: 10.1212/wnl.53.1.85.

DOI:10.1212/wnl.53.1.85
PMID:10408541
Abstract

OBJECTIVE

To reduce antiparkinsonian medication in parkinsonian patients with bilateral high frequency subthalamic nucleus (STN) stimulation.

BACKGROUND

Parkinsonian syndromes are characterized by hyperactivity of the STN. Preliminary data indicate that functional inactivation of the STN may reduce the requirement for dopaminergic therapy in PD.

METHODS

Bilateral quadripolar leads were implanted stereotactically in the STN of seven patients with advanced PD (mean age, 57.4 years; mean disease duration, 15.4 years). High-frequency stimulation was applied for 24 hours a day. Following implantation, antiparkinsonian medication was reduced to the minimum possible and stimulation was gradually increased. The patients were evaluated in the practically defined "off" and "on" conditions using the Unified Parkinson's Disease Rating Scale (UPDRS) and the Schwab & England scale. The average follow-up was 16.3+/-7.6 months. A battery of neuropsychological tests was applied before and 9 months after the implant.

RESULTS

Parkinsonian features improved in all patients--the greatest change seen in rigidity, then tremor, followed by bradykinesia. Compared with the presurgical condition, off-drug UPDRS motor scores improved by 41.9% on the last visit (p = 0.0002), UPDRS activities of daily living (ADL) scores improved by 52.2% (p = 0.0002), and the Schwab & England scale score improved by 213% (p = 0.0002). The levodopa-equivalent daily dose was reduced by 65%. Night sleep improved in all patients due to increased mobility at night, and in five patients insomnia was resolved. All patients gained weight after surgery and their appetite increased. The mean weight gain at the last follow-up was 13% compared with before surgery. During the last visit, the stimulation amplitude was 2.9+/-0.5 V and the total energy delivered per patient averaged 2.7+/-1.4 W x10(-6). The results of patient self-assessment scales indicated a marked improvement in five patients and a moderate improvement in the other two. The neuropsychological data showed no changes. Side effects were mild and tolerable. In all cases, a tradeoff between the optimal voltage and the severity of side effects made it possible to control parkinsonian signs effectively. The most marked side effects directly related to STN stimulation consisted of ballistic or choreic dyskinesias of the neck and the limbs elicited by contralateral STN stimulation above a given threshold voltage, which varied depending on the individual.

CONCLUSIONS

Parkinsonian signs can be controlled by bilateral high-frequency STN stimulation. The procedure is well tolerated. On-state dyskinesias were greatly reduced, probably due to the reduction of total antiparkinsonian medication. Bilateral high-frequency STN stimulation compensated for drug reduction and elicited dyskinesias, which differ from those observed following dopaminergic medication. ADL improved significantly, suggesting that some motor tasks performed during everyday chores, and that are not taken into account in the UPDRS motor score, also improved.

摘要

目的

减少双侧高频丘脑底核(STN)刺激的帕金森病患者的抗帕金森药物用量。

背景

帕金森综合征的特征是STN功能亢进。初步数据表明,STN的功能失活可能会降低帕金森病患者对多巴胺能治疗的需求。

方法

对7例晚期帕金森病患者(平均年龄57.4岁;平均病程15.4年)进行立体定向双侧四极电极植入STN。每天进行24小时高频刺激。植入后,将抗帕金森药物减至尽可能低的水平,并逐渐增加刺激强度。使用统一帕金森病评定量表(UPDRS)和施瓦布与英格兰量表在实际定义的“关”和“开”状态下对患者进行评估。平均随访时间为16.3±7.6个月。在植入前和植入后9个月进行一系列神经心理学测试。

结果

所有患者的帕金森病症状均有改善——僵硬改善最明显,其次是震颤,然后是运动迟缓。与术前相比,末次随访时停药状态下UPDRS运动评分提高了41.9%(p = 0.0002),UPDRS日常生活活动(ADL)评分提高了52.2%(p = 0.0002),施瓦布与英格兰量表评分提高了213%(p = 0.0002)。左旋多巴等效日剂量减少了65%。所有患者夜间睡眠因夜间活动增加而改善,5例患者失眠得到解决。所有患者术后体重增加,食欲增强。末次随访时平均体重较术前增加了13%。末次随访时,刺激幅度为2.9±0.5V,每位患者的总能量平均为2.7±1.4W×10⁻⁶。患者自我评估量表结果显示,5例患者有显著改善,另外2例有中度改善。神经心理学数据无变化。副作用轻微且可耐受。在所有病例中,通过在最佳电压和副作用严重程度之间进行权衡,可以有效控制帕金森病体征。与STN刺激直接相关的最明显副作用包括在给定阈值电压以上由对侧STN刺激引起的颈部和肢体的弹道样或舞蹈样运动障碍,其因个体而异。

结论

双侧高频STN刺激可控制帕金森病体征。该手术耐受性良好。“开”状态下的运动障碍大大减少,可能是由于抗帕金森药物总量的减少。双侧高频STN刺激弥补了药物减量并引发了运动障碍,这些运动障碍与多巴胺能药物治疗后观察到的不同。ADL有显著改善,表明日常琐事中执行的一些运动任务(这些任务在UPDRS运动评分中未被考虑)也得到了改善。

相似文献

1
Chronic subthalamic nucleus stimulation reduces medication requirements in Parkinson's disease.慢性丘脑底核刺激可降低帕金森病患者的药物需求。
Neurology. 1999 Jul 13;53(1):85-90. doi: 10.1212/wnl.53.1.85.
2
Bilateral high frequency subthalamic stimulation in Parkinson's disease: long-term neurological follow-up.帕金森病双侧高频丘脑底核刺激:长期神经学随访
J Neurosurg Sci. 2003 Sep;47(3):119-28.
3
Deep brain stimulation of the subthalamic nucleus for control of extrapyramidal features in advanced idiopathic parkinson's disease: one year follow-up.丘脑底核深部脑刺激术治疗晚期特发性帕金森病锥体外系症状的一年随访
J Neural Transm (Vienna). 1999;106(7-8):693-709. doi: 10.1007/s007020050190.
4
Subthalamic nucleus stimulation for Parkinson disease: benefits observed in levodopa-intolerant patients.丘脑底核刺激治疗帕金森病:在左旋多巴不耐受患者中观察到的益处
J Neurosurg. 2001 Aug;95(2):213-21. doi: 10.3171/jns.2001.95.2.0213.
5
Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson disease.晚期帕金森病双侧丘脑底核刺激后左旋多巴撤药
Arch Neurol. 2000 Jul;57(7):983-8. doi: 10.1001/archneur.57.7.983.
6
Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.帕金森病患者双侧丘脑底核刺激对左旋多巴的反应。
Brain. 2002 Nov;125(Pt 11):2408-17. doi: 10.1093/brain/awf249.
7
Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation.轴性帕金森症状可得到改善:左旋多巴和双侧丘脑底核刺激的作用。
J Neurol Neurosurg Psychiatry. 2000 May;68(5):595-600. doi: 10.1136/jnnp.68.5.595.
8
Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease.丘脑底核或苍白球内侧部刺激术治疗早发型帕金森病
Brain. 1998 Mar;121 ( Pt 3):451-7. doi: 10.1093/brain/121.3.451.
9
Subthalamic nucleus stimulation in Parkinson's disease: clinical evaluation of 18 patients.帕金森病中丘脑底核刺激:18例患者的临床评估
J Neurol. 2002 May;249(5):529-34. doi: 10.1007/s004150200059.
10
Bilateral subthalamic nucleus stimulation in advanced Parkinson's disease: three years follow-up.晚期帕金森病双侧丘脑底核刺激:三年随访
J Neurol. 2007 Jan;254(1):99-106. doi: 10.1007/s00415-006-0297-6. Epub 2007 Feb 14.

引用本文的文献

1
Deep brain stimulation and Parkinson disease: a bibliometric and visual analysis (1993-2023).深部脑刺激与帕金森病:文献计量学与可视化分析(1993 - 2023年)
Neurosurg Rev. 2025 Jan 7;48(1):24. doi: 10.1007/s10143-025-03178-w.
2
The impact of subthalamic deep-brain stimulation in restoring motor symmetry in Parkinson's disease patients: a prospective study.丘脑底核电刺激对帕金森病患者运动对称性恢复的影响:一项前瞻性研究。
J Neurol. 2024 May;271(5):2582-2595. doi: 10.1007/s00415-023-12162-7. Epub 2024 Feb 9.
3
Complications of deep brain stimulation in Parkinson's disease: a single-center experience of 517 consecutive cases.
深部脑刺激治疗帕金森病的并发症:单中心 517 例连续病例经验。
Acta Neurochir (Wien). 2023 Nov;165(11):3385-3396. doi: 10.1007/s00701-023-05799-w. Epub 2023 Sep 29.
4
Anticipatory Postural Adjustments and Compensatory Postural Responses to Multidirectional Perturbations-Effects of Medication and Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease.帕金森病中对多向扰动的预期姿势调整和代偿性姿势反应——药物治疗和丘脑底核深部脑刺激的影响
Brain Sci. 2023 Mar 7;13(3):454. doi: 10.3390/brainsci13030454.
5
Axial impairment and falls in Parkinson's disease: 15 years of subthalamic deep brain stimulation.帕金森病的轴性损害与跌倒:丘脑底核深部脑刺激治疗15年
NPJ Parkinsons Dis. 2022 Sep 24;8(1):121. doi: 10.1038/s41531-022-00383-y.
6
Volumetric analysis of subthalamic nucleus and red nucleus in patients of advanced Parkinson's disease using SWI sequences.使用SWI序列对晚期帕金森病患者的丘脑底核和红核进行容积分析。
Surg Neurol Int. 2021 Jul 27;12:377. doi: 10.25259/SNI_584_2021. eCollection 2021.
7
A Systematic Review of Neuromodulation Treatment Effects on Suicidality.神经调节治疗对自杀倾向影响的系统评价
Front Hum Neurosci. 2021 Jun 25;15:660926. doi: 10.3389/fnhum.2021.660926. eCollection 2021.
8
Deep Brain Stimulation of the Subthalamic Nucleus Modulates Reward-Related Behavior: A Systematic Review.丘脑底核的深部脑刺激调节奖赏相关行为:一项系统评价。
Front Hum Neurosci. 2020 Nov 20;14:578564. doi: 10.3389/fnhum.2020.578564. eCollection 2020.
9
Weight Loss and Malnutrition in Patients with Parkinson's Disease: Current Knowledge and Future Prospects.帕金森病患者的体重减轻与营养不良:当前认知与未来展望
Front Aging Neurosci. 2018 Jan 19;10:1. doi: 10.3389/fnagi.2018.00001. eCollection 2018.
10
Deep Brain Stimulation-Possible Treatment Strategy for Pathologically Altered Body Weight?深部脑刺激——治疗病理性体重改变的可能策略?
Brain Sci. 2018 Jan 22;8(1):19. doi: 10.3390/brainsci8010019.